(Q45220473)

11 December 2017

1 reference

title

The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression (English)

1 reference

11 December 2017

Mario F Juruena

1

1 reference

11 December 2017

Mario F Juruena

series ordinal

2

1 reference

11 December 2017

Anthony J Cleare

series ordinal

3

1 reference

11 December 2017

Carmine M Pariante

series ordinal

4

1 reference

11 December 2017

language of work or name

non-English

0 references

publication date

1 September 2004

1 reference

Brazilian Journal of Psychiatry

11 December 2017

published in

1 reference

11 December 2017

volume

26

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

189-201

1 reference

The neuroendocrinology of depression and chronic stress

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Do panic disorder and posttraumatic stress disorder share a common psychoneuroendocrinology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Urinary free cortisol in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Future therapeutic targets in mood disorders: the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Loss of Glucocorticoid Fast Feedback in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Effects of antenatal stress and anxiety: Implications for development and psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

The Ernst Schering Poster Award. Intracellular traffic of steroid hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Treatment of major depression with steroid suppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Stress and the progression of the developmental hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Immunoglobulin production in vitro in major depression: a pilot study on the modulating action of endogenous cortisol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Altered glucocorticoid immunoregulation in treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Vasoconstrictor response to topical beclomethasone in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Bone mineral density in women with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Glucocorticoid resistant syndromes--molecular basis and clinical presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

The Yin and Yang of nuclear receptors: symposium on nuclear receptors in brain, Oegstgeest, The Netherlands, 13-14 April 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Do antidepressants regulate how cortisol affects the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

21 January 2018

Steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

The DST as a predictor of outcome in depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Clinical applications of the dexamethasone suppression test for endogenous depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

Pituitary volume in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000300009

10.1590/S1516-44462004000300009

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference